The Medtronic Infuse Bone Graft has caused the medical community to be concerned as a hundreds of individuals have experienced adverse Infuse Bone Graft side effects. These side effects often have resulted from off-label use of the Infuse Bone Graft, which Medtronic Inc. allegedly encouraged.

This has led to over 1,000 Medtronic Infuse Bone Graft lawsuits to be filed over Infuse Bone Graft complications. 

The Medtronic Infuse bone graft has been U.S. Food and Drug Administration (FDA) approved for certain spinal fusion surgeries: specifically, the anterior approach lumber fusion surgery. It has also been approved for certain dental surgeries. Medtronic has been accused of promoting the Infuse Bone Graft for cervical spinal fusion as well, which the FDA specifically stated was not approved.

It is not illegal for doctors to use the Infuse Bone Graft for off-label purposes, but it is illegal for Medtronic to promote their product for off-label uses. The medical device maker may be held legally responsible for thousands of Infuse bone graft side effects.

Infuse Bone Graft side effects include cancer, difficulty swallowing, breathing and speaking, uncontrolled bone growth, nerve injuries, chronic pain, male sterility, and cauda equina syndrome.

What is the Medtronic Infuse Bone Graft?

The Medtronic Infuse Bone Graft is a device that encourages bone growth in the spine. It uses a protein called rhBMP-2 to encourage growth in spinal fusion surgery. It is an alternative to the traditional bone grafting method which can also be used for spinal repair.

Infuse Bone Graft complications have been known to the medical community for quite some time. In 2013, the National Center for Biotechnology Information suggested that the Medtronic Infuse Bone Graft could cause a potentially deadly problem during revision surgery involving vascular injuries.

Medtronic allegedly bribed doctors to hide Infuse Bone Graft side effects from the public. Medtronic’s studies on Infuse Bone Graft safety supposedly hid potential safety issues. One study published in the Spine Journal suggested that 10 percent to 50 percent of patients studied experienced adverse Medtronic Infuse Bone Graft complications.

Medtronic Infuse Bone Graft Lawsuits

Hundreds of Medtronic Infuse Bone Graft lawsuits have been filed against Medtronic.  

Medtronic submitted a motion to dismiss a Medtronic class action lawsuit that stated Medtronic was involved in a scheme that misled investors particularly in the area of Infuse Bone Graft side effects. It was also suggested that Medtronic’s initial studies involving Infuse Bone Graft complications were inaccurate and misleading.

The judge denied the motion to dismiss the Medtronic class action lawsuit. Medtronic’s stock suffered as a result of the allegations made in this Medtronic Infuse Bone Graft lawsuit.

Individuals who have experienced negative Medtronic Infuse Bone Graft complications such as uncontrolled bone growth, difficulty breathing, male sterility, or cancer have filed a Medtronic Infuse Bone Graft lawsuit or have joined a Medtronic class action lawsuit.